The use of treatable traits to address COPD complexity and heterogeneity and to inform the care

K Duszyk, RF McLoughlin, PG Gibson, VM McDonald - Breathe, 2021 - Eur Respiratory Soc
COPD is complex and heterogeneous with respect to its aetiology, clinical presentation,
phenotypes and biological mechanisms. Despite this, COPD is still diagnosed and treated …

Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease

D Bouhuis, M Giezeman, M Hasselgren… - … Journal of Chronic …, 2023 - Taylor & Francis
Background Patients with chronic obstructive pulmonary disease (COPD) and no
exacerbations may need less maintenance treatment and follow-up. The aim was to identify …

Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes

Z Ji, J Hernández-Vázquez… - … Journal of Chronic …, 2020 - Taylor & Francis
Background Chronic obstructive pulmonary disease (COPD) usually occurs alongside other
conditions. Few studies on comorbidities have taken into account the phenotypes of COPD …

Phenotypes of COPD in an Austrian population: national data from the POPE study

G Reiger, R Zwick, B Lamprecht, C Kähler… - Wiener Klinische …, 2018 - Springer
Background Chronic obstructive pulmonary disease (COPD) represents a major global
health problem; however, there are no data regarding clinical phenotypes of these patients …

[PDF][PDF] Chronic Obstructive Pulmonary Disease Biomarkers.

T Beiko, C Strange - Eurasian Journal of Pulmonology, 2016 - jag.journalagent.com
Despite significant decreases in morbidity and mortality of cardiovascular diseases (CVD)
and cancers, morbidity and cost associated with chronic obstructive pulmonary disease …

Personalized medicine in COPD treatment

N Shen, B He - Current Respiratory Care Reports, 2014 - Springer
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, and not all
patients respond to all currently available drugs. The importance of personalized treatment …

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

PMA Calverley, PS Burge, S Spencer, JA Anderson… - Thorax, 2003 - thorax.bmj.com
Background: A limited or absent bronchodilator response is used to classify chronic
obstructive pulmonary disease (COPD) and can determine the treatment offered. The …

COPD phenotypes according to high resolution CT scan findings

A Shah, U Shah, TK Jayalakshmi… - European …, 2014 - Eur Respiratory Soc
[BACKGROUND] High Resolution Computed Tomography Scan (HRCT) is now being used
as an important diagnostic test in COPD patients. In present study, we have evaluated …

Introduction to precision medicine in COPD

JM Leung, M Obeidat, M Sadatsafavi… - European Respiratory …, 2019 - Eur Respiratory Soc
Although there has been tremendous growth in our understanding of chronic obstructive
pulmonary disease (COPD) and its pathophysiology over the past few decades, the pace of …

A clinical prediction model for hospitalized COPD exacerbations based on “treatable traits”

ACA Yii, CH Loh, PY Tiew, H Xu… - … journal of chronic …, 2019 - Taylor & Francis
Background Assessing risk of future exacerbations is an important component in COPD
management. History of exacerbation is a strong and independent predictor of future …